Join SNBL from July 15 to 18 in Honolulu for the 15th International Congress of Toxicology. Drop by Booth 401 or email email@example.com to see how SNBL can provide preclinical support for your drug development program.
SNBL is known for its high quality developmental and reproductive preclinical studies, and we would be happy to discuss how we can help your drug development program at the annual Teratology Society Meeting in San Diego this June. Email firstname.lastname@example.org to make an appointment or visit Booth #4.
Are you attending BIO 2019 in Philadelphia June 3-6? SNBL will be at the JETRO booth #1509, and we would be happy to discuss how our preclinical safety testing can support your drug development program. Email email@example.com to make an appointment.
SNBL will be exhibiting at ARVO, The Association for Research in Vision and Ophthalmology, to be held in Vancouver from April 28 to May 2. We will be at Booth #1643 to introduce our new capability of OCT angiography for preclinical evaluation. Email us at firstname.lastname@example.org to set up a meeting.
One of our pathologists at SNBL, Haruno Yabuki, DVM, received the top honorable mention for a poster she presented at the 35th Scientific Meeting of the Japanese Society of Toxicologic Pathology (JSTP). This meeting is a gathering of nearly all toxicologic pathologists in Japan, whether from pharmaceutical companies or CROs, educational institutions, or public research institutions, and was a great opportunity to show SNBL’s high level of scientific quality.
Congratulations Dr. Yabuki!
For the third year in a row, SNBL Japan received the Health & Productivity Award, presented by the Japanese Ministry of Economy, Trade and Industry. This award recognizes organizations which promote health in their region by implementing strategies to improve the health and productivity of their employees.
As part of its strategy to improve employee health, SNBL Japan has implemented Wellness Tourism seminars, a series of health challenges, and early cancer screenings. SNBL Japan will strive to continue these efforts and ensure that the recognition of our strategy is meaningful.
We have updated our publications section. We look forward to seeing the research that will be presented in 2019.
We will host a joint seminar with Taiwan Research-Based Biopharmaceutical Manufacturers Association (TRPMA) in Taipei on January 23, 2019.
Up to now, drug development in Taiwan has largely operated based on manufacturing contracts; however, successful new drug development has seen an increase in active support from Taiwanese government policy.
SNBL will give lectures to Taiwanese pharmaceutical and biotech companies with the aim of shedding light on the current situation in Japan including topics such as the conduct of GLP studies and GLP monitoring authority in Japan, preclinical studies on biologics and advanced therapy products, and application of imaging techniques to pharmacology and toxicity studies.
This seminar will work to enhance mutual understanding and exchange ideas between Japan and Taiwan in order to facilitate drug development activities in both countries.
We have updated our posters section. We look forward to seeing the research that will be presented in the new year.
SNBL has received the 2018 Prime Minister's Award for leading businesses in the promotion of women from the Gender Equality Bureau Cabinet Office. This award recognizes companies that make a proactive effort in supporting women in managerial and executive positions. SNBL is the first company in Kagoshima to receive this award. SNBL knows that the viewpoints of women are essential not only to a successful business, but also to a prosperous society. We are honored to receive this award and hope that our practices can be a model for the rest of Kagoshima.
The Japanese Ministry of Health, Labour and Welfare (MHLW) gives annual awards to companies promoting equality in the workplace, and this year SNBL is one of two awardees of the MHLW's Award of Excellence. This award goes to companies that make exemplary efforts in proactively giving women the chance to demonstrate their ability, as well as supporting a good balance between career and child-rearing or caregiving. The official award ceremony will be held on January 16, 2019 in Tokyo.
SNBL is honored to receive this award and will continue providing a work environment in which equal opportunity can thrive, regardless of gender, race, age, disability, etc.
On August 3, 2018, at the Taiwan 2018 Latest Business Seminar in Tokyo, SNBL and Medgaea Life Sciences Ltd. (MDG) signed a Memorandum of Understanding (MOU). The MOU, signed by Dr. Chih-Chun Hong, Chief Executive Officer of MDG, and Koichiro Fukuzaki, Executive Vice Chairman of SNBL, confirms the intention of SNBL and MDG to collaborate more closely.
MDG was established in Taiwan in 2005 and offers a variety of pre-clinical contract research services for health foods, herbal medicine, medical devices, and chemical products. SNBL and MDG will promote and support R&D of drugs, medical devices, and regenerative medicine in Taiwan.